Download PDF
CC BY-NC-ND 4.0 · World J Nucl Med 2020; 19(02): 171-173
DOI: 10.4103/wjnm.WJNM_98_18
Case Report

Reactive changes with microfilaria in a suspected metastatic axillary lymph node on positron emission tomography–computed tomography in breast malignancy: An interesting finding

Anuja Anand
Department of Nuclear Medicine and PET-CT, Max Super Speciality Hospital, New Delhi
,
Aarti Tyagi
1   Department of Pathology, Max Super Speciality Hospital, New Delhi
,
Shubham Jain
2   Department of Oncosurgery, Max Super Speciality Hospital, New Delhi, India
,
Pankaj Dougall
Department of Nuclear Medicine and PET-CT, Max Super Speciality Hospital, New Delhi
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Positron emission tomography–computed tomography (PET-CT) has evolved as an important diagnostic tool in the diagnosis and management of breast carcinoma. PET/CT can help in staging as well as detecting metastases to mediastinal, axillary, and internal mammary nodes. However, PET-CT is not useful in differentiating between inflammation and malignancy.

Keywords

Breast cancer - microfilaria - positron emission tomography–computed tomography

Financial support and sponsorship

Nil.




Publication History

Received: 02 November 2018

Accepted: 20 November 2018

Article published online:
19 April 2022

© 2020. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Paydary K, Seraj SM, Zadeh MZ, Emamzadehfard S, Shamchi SP, Gholami S, et al. The evolving role of FDG-PET/CT in the diagnosis, staging, and treatment of breast cancer. Mol Imaging Biol 2018;30:1536-632.
  • 2 Soerjomataram I, Louwman MW, Ribot JG, Roukema JA, Coebergh JW. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 2008;107:309-30.
  • 3 Farghaly H, Nasr H, Al Qami A. Role of FDG PET/CT in infection and inflammation. J Nucl Med 2015;30:314-19.
  • 4 Caoduro C, Porot C, Vuitton DA, Bresson-Hadni S, Grenouillet F, Richou C, et al. The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis. J Nucl Med 2013;54:358-63.